Free Trial
LON:BXP

Beximco Pharmaceuticals (BXP) Share Price, News & Analysis

Beximco Pharmaceuticals logo
GBX 45.09 -1.41 (-3.03%)
As of 04:21 AM Eastern

About Beximco Pharmaceuticals Stock (LON:BXP)

Advanced

Key Stats

Today's Range
45.09
46.50
50-Day Range
39
50
52-Week Range
23
52.33
Volume
11,804 shs
Average Volume
47,705 shs
Market Capitalization
£201.15 million
P/E Ratio
3.16
Dividend Yield
8.80%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BXP Stock News Headlines

Claim Your Share of $5.39 BILLION in AI Equity Checks
The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enforcing that means a $5.39 billion pot must be paid out to everyday Americans. See, virtually every AI model is built off stolen data...tc pixel
See More Headlines

BXP Stock Analysis - Frequently Asked Questions

Beximco Pharmaceuticals' stock was trading at GBX 38.20 at the beginning of 2025. Since then, BXP shares have increased by 18.0% and is now trading at GBX 45.09.

Shares of BXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Beximco Pharmaceuticals investors own include Advanced Micro Devices (AMD), Bank of America (BAC), Exxon Mobil (XOM), Salesforce (CRM), Chevron (CVX), Meta Platforms (META) and NIKE (NKE).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Trading
Current Symbol
LON:BXP
CIK
N/A
Fax
N/A
Employees
5,500
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 14.25
Trailing P/E Ratio
3.19
Forward P/E Ratio
5.08
P/E Growth
N/A
Net Income
£970.84 billion
Net Margins
13.71%
Pretax Margin
N/A
Return on Equity
13.12%
Return on Assets
6.97%

Debt

Debt-to-Equity Ratio
12.47
Current Ratio
2.13
Quick Ratio
0.37

Sales & Book Value

Annual Sales
£46.34 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
£120.21 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
446,112,000
Free Float
N/A
Market Cap
£202.98 million
Optionable
Not Optionable
Beta
0.61
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (LON:BXP) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners